Duquesne Family Office LLCDuquesne Family Office LLC

Institutional investor · Portfolio as of Q4 2025

SEC EDGAR SourceSEC Filings

Top Holdings62 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

NATERA INC

2.5M$575.3M12.8%$98.33+133.90%
14 qtrssince 2022-Q3
Decreased
0
XLFXLF
ETF

FINANCIAL SELECT SECTOR SPDR

5.5M$301M6.7%$55.18+5.40%
1 qtr
New
95

INSMED INC

1.5M$257.9M5.7%$88.05+97.71%
7 qtrssince 2024-Q2
Decreased
0
RSPRSP
ETF

INVESCO S&P 500 EQUAL WEIGHT

1.2M$224.9M5.0%$193.21+15.30%
1 qtr
New
95
TEVATEVA
ADR

TEVA PHARMACEUTICAL-SP ADR

5.9M$183.4M4.1%$18.85+66.24%
6 qtrssince 2024-Q3
Decreased
0

WOODWARD INC

590,930$178.7M4.0%$150.13+101.90%
9 qtrssince 2023-Q4
Decreased
0

AMAZON.COM INC

737,940$170.3M3.8%$226.39+2.71%
2 qtrssince 2025-Q3
Increased
83
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

543,085$165M3.7%$180.59+65.89%
6 qtrssince 2024-Q3
Decreased
0

COUPANG INC

6.8M$159.8M3.6%$30.83-21.72%
20 qtrssince 2021-Q1
Increased
76
EWZEWZ
CALL

ISHARES MSCI BRAZIL ETF

4.2M$134.3M3.0%
New

ALPHABET INC-CL A

385,000$120.5M2.7%$295.28+17.14%
2 qtrssince 2025-Q3
Increased
83
SESE
ADR

SEA LTD-ADR

944,120$120.4M2.7%$137.34-6.55%
3 qtrssince 2025-Q2
Increased
83
EWZEWZ
ETF

ISHARES MSCI BRAZIL ETF

3.6M$112.9M2.5%$31.990.00%
1 qtr
New
78

NewAmsterdam Pharma Company N.V.

3.1M$107.7M2.4%$28.10+23.61%
6 qtrssince 2024-Q3
Increased
74

MERCADOLIBRE INC

47,149$95M2.1%$1,802.75+12.10%
7 qtrssince 2024-Q2
Decreased
0

BBB FOODS INC

2.7M$89.3M2.0%$30.60+9.34%
3 qtrssince 2025-Q2
Increased
76

RESTAURANT BRANDS INTERN

1.2M$82.5M1.8%$64.72+6.23%
3 qtrssince 2025-Q2
Increased
50

Cogent Biosciences, Inc.

2.2M$78.7M1.8%$26.12+45.22%
2 qtrssince 2025-Q3
Increased
76

ALCOA CORP

1.4M$73.1M1.6%$52.870.00%
1 qtr
New
68

ENTEGRIS INC

844,160$71.1M1.6%$84.05+92.46%
1 qtr
New
68
$4.5B
AUM
62
Positions
Q4 2025
Filing
Rating · 2.5
Quarterly Portfolio Change
+1%Q3'24$3B+26%Q4'24$3.7B-18%Q1'25$3.1B+33%Q2'25$4.1B-0%Q3'25$4.1B+11%Q4'25$4.5B
Activity profile
$ moved · Q4'25
New39%Increased15%Decreased18%Exited27%
Composition
Equity vs derivatives
Equity94%Puts0%Calls6%
Holding period
Avg 2.1 years
<1Q26%1-4Q24%1-2Y16%2Y+34%

Duquesne Family Office LLC manages $4.5B across 62 positions as of Q4 2025. Top holdings: NTRA (12.8%), XLF (6.7%), INSM (5.7%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2.5/5.0.

Q4 2025 Summary

Active quarter - 26 new positions, 30 exits, 13 increased. Top move: XLF (NEW, conviction 95). Portfolio: $4.5B across 62 positions.

Top holdings by portfolio weight

Total AUM$4B
NTRA12.80%
XLF6.70%
INSM5.74%
RSP5.00%
TEVA4.08%
WWD3.97%
AMZN3.79%
TSM3.67%
CPNG3.55%
GOOGL2.68%
Other2.68%

Portfolio allocation by GICS sector

Sectors10
Healthcare30.77%
Consumer Cyclical16.38%
Unknown16.31%
Technology11.51%
Industrials10.31%
Communication Services5.56%
Basic Materials4.20%
Consumer Defensive2.37%
Financial Services2.08%
Energy0.52%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Healthcare, Consumer Cyclical, Unknown
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track RecordNo data
Conviction48
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
2Q
ADMAADMAADMA BIOLOGICS INC
Q1 2026 Q2 2026+2.5M shares-$4.6M
2Q
CLFCLFCLEVELAND-CLIFFS INC
Q1 2026 Q2 2026+2.5M shares-$23.1M
2Q
NTRANTRANATERA INC
Q1 2026 Q2 2026+674,949 shares-$574.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used